Literature DB >> 23307776

Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study.

Phong T Lee1, Marc R Dweck, Sparsh Prasher, Anoop Shah, Steve E Humphries, Dudley J Pennell, Hugh E Montgomery, John R Payne.   

Abstract

BACKGROUND: To use cardiovascular magnetic resonance to investigate left ventricular wall thickness and the presence of asymmetrical hypertrophy in young army recruits before and after a period of intense exercise training. METHODS AND
RESULTS: Using cardiovascular magnetic resonance, the left ventricular wall thickness was measured in all 17 segments and a normal range was calculated for each. The prevalence of asymmetrical wall thickening was assessed before and after training and defined by a ventricular wall thickness ≥13.0 mm that was >1.5× the thickness of the opposing myocardial segment. Five hundred forty-one men (mean age, 20±2 years) were recruited, 309 underwent repeat scanning. Considerable variation in wall thickness was observed across the ventricle with progressive thickening on moving from the apex to base (P<0.001) and in the basal and midcavity septum compared with the lateral wall (11.0±1.4 versus 10.1±1.3 mm; P<0.001). Twenty-three percent had a maximal wall thickness ≥13.0 mm, whereas the prevalence of asymmetrical wall thickening increased from 2.2% to 10% after the exercise-training program. In those who developed asymmetry, the wall thickness/diastolic volume ration remained normal (0.09±0.02 mm⋅m(2)⋅mL(-1)), indicative of a remodeling response to exercise.
CONCLUSIONS: In a cohort of healthy young white men, we have demonstrated that wall thickness frequently measures ≥13.0 mm and that asymmetrical wall thickening is common and can develop as part of the physiological response to exercise. A diagnosis of hypertrophic cardiomyopathy in young athletic men should, therefore, not be made purely on the basis of regional wall thickening.

Entities:  

Mesh:

Year:  2013        PMID: 23307776     DOI: 10.1161/CIRCIMAGING.112.979294

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  9 in total

1.  Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy.

Authors:  Fatih Yalçin; Nagehan Kucukler; Oscar Cingolani; Blaid Mbiyangandu; Lars Sorensen; Aurelio Pinherio; M Roselle Abraham; Theodore P Abraham
Journal:  J Appl Physiol (1985)       Date:  2018-01-04

2.  Segmental Analysis of Cardiac Short-Axis Views Using Lagrangian Radial and Circumferential Strain.

Authors:  Chi Ma; Xiao Wang; Tomy Varghese
Journal:  Ultrason Imaging       Date:  2015-11-16       Impact factor: 1.578

3.  The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.

Authors:  Csilla Czimbalmos; Ibolya Csecs; Attila Toth; Orsolya Kiss; Ferenc Imre Suhai; Nora Sydo; Zsofia Dohy; Astrid Apor; Bela Merkely; Hajnalka Vago
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

4.  Cardiac MRI improves cardiovascular risk stratification in hazardous occupations.

Authors:  David A Holdsworth; Iain T Parsons; Rebecca Chamley; Joseph Britton; Christopher Pavitt; A John Baksi; Stefan Neubauer; Joanna d'Arcy; Edward D Nicol
Journal:  J Cardiovasc Magn Reson       Date:  2019-07-29       Impact factor: 5.364

Review 5.  Basal Septal Hypertrophy as the Early Imaging Biomarker for Adaptive Phase of Remodeling Prior to Heart Failure.

Authors:  Fatih Yalçin; Hulya Yalçin; Nagehan Küçükler; Serbay Arslan; Oguz Akkuş; Alparslan Kurtul; Maria Roselle Abraham
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

6.  Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.

Authors:  Jonathan C L Rodrigues; Stephen Rohan; Amardeep Ghosh Dastidar; Iwan Harries; Christopher B Lawton; Laura E Ratcliffe; Amy E Burchell; Emma C Hart; Mark C K Hamilton; Julian F R Paton; Angus K Nightingale; Nathan E Manghat
Journal:  Eur Radiol       Date:  2016-07-01       Impact factor: 5.315

7.  Fully implantable and bioresorbable cardiac pacemakers without leads or batteries.

Authors:  Yeon Sik Choi; Rose T Yin; Anna Pfenniger; Jahyun Koo; Raudel Avila; K Benjamin Lee; Sheena W Chen; Geumbee Lee; Gang Li; Yun Qiao; Alejandro Murillo-Berlioz; Alexi Kiss; Shuling Han; Seung Min Lee; Chenhang Li; Zhaoqian Xie; Yu-Yu Chen; Amy Burrell; Beth Geist; Hyoyoung Jeong; Joohee Kim; Hong-Joon Yoon; Anthony Banks; Seung-Kyun Kang; Zheng Jenny Zhang; Chad R Haney; Alan Varteres Sahakian; David Johnson; Tatiana Efimova; Yonggang Huang; Gregory D Trachiotis; Bradley P Knight; Rishi K Arora; Igor R Efimov; John A Rogers
Journal:  Nat Biotechnol       Date:  2021-06-28       Impact factor: 68.164

8.  T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy.

Authors:  Shi Chen; Liwei Huang; Qing Zhang; Jie Wang; Yucheng Chen
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

9.  Myocardial Aspects in Aortic Stenosis and Functional Increased Afterload Conditions in Patients with Stressed Heart Morphology.

Authors:  Fatih Yalçin; Roselle Abraham; Theodore P Abraham
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-07-07       Impact factor: 1.520

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.